0001404644-24-000008.txt : 20240314 0001404644-24-000008.hdr.sgml : 20240314 20240314205321 ACCESSION NUMBER: 0001404644-24-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240313 FILED AS OF DATE: 20240314 DATE AS OF CHANGE: 20240314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cvijic Christine Mikail CENTRAL INDEX KEY: 0001543663 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 24752209 MAIL ADDRESS: STREET 1: 1301 2ND AVE., SUITE 3200 CITY: SEATTLE STATE: WA ZIP: 98101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neurogene Inc. CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980542593 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 W 24TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: (877) 237-5020 MAIL ADDRESS: STREET 1: 535 W 24TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 FORMER COMPANY: FORMER CONFORMED NAME: Neoleukin Therapeutics, Inc. DATE OF NAME CHANGE: 20190812 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC DATE OF NAME CHANGE: 20140128 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 4 1 wk-form4_1710463991.xml FORM 4 X0508 4 2024-03-13 0 0001404644 Neurogene Inc. NGNE 0001543663 Cvijic Christine Mikail C/O NEUROGENE INC. 535 W 24TH STREET, 5TH FLOOR NEW YORK NY 10011 0 1 0 0 President and CFO 0 Common Stock 2024-03-13 4 A 0 31903 0 A 52844 D Employee Stock Option (Right to buy) 36.06 2024-03-13 4 A 0 53900 0 A 2034-03-13 Common Stock 53900 53900 D The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date. /s/ Christine Mikail 2024-03-14